Covid-19: Vaccine Donations

Lord Bilimoria Excerpts

Monday 29th November 2021 Lords Chamber

[Lord Goldsmith of Richmond Park (Con)]

As my noble friend will know, COVAX is designed to work for both high and middle-income countries; this allows for the pooling of investments behind early vaccine candidates. The UK has procured 539,370 doses of the Pfizer vaccine through COVAX; those were delivered early this year. These doses help the NHS to deliver our vaccination programme as quickly as possible. No further doses have been received by the UK from COVAX. I am afraid I cannot answer my noble friend’s question on the waste of unused vaccines, but clearly, it is in all our interests and a key priority that we minimise any potential waste.

[Lord Bilimoria (CB)]

My Lords, in May this year, as president of the CBI, I chaired the B7. Dr Gita Gopinath, chief economist of the IMF, spoke at it and in May sent me a report called A Proposal to End the COVID-19 Pandemic. It would cost $50 billion to vaccinate the whole world by the first half of 2022. If one company, Serum Institute of India, can produce 1 billion vaccines, surely the Minister and the Government agree that we should follow the recommendations of this report, pull together and end this pandemic. Until we are all safe, no one is safe.

[Lord Goldsmith of Richmond Park (Con)]

The noble Lord is absolutely right that until we are all safe, no one is safe. That is why the UK has been if not the biggest contributor then certainly one of the biggest contributors to the COVAX scheme. As the noble Lord says, making vaccines available globally not only helps to end the pandemic in developing countries but reduces the threat posed by vaccine-resistant variants emerging in areas with large-scale outbreaks, which of course threatens the UK. It is in all our interests that we do so.